Showing results (191-200 of 509) with videos related to

Sort By:
Pageof 51
Breast Cancer Research and Treatment|April 23, 2021
Prognostic value of the 21-gene recurrence score for regional recurrence in patients with estrogen receptor-positive breast cancerMinji Koh, Jinhong Jung, Su Ssan Kim, et al.
The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society|March 20, 2018
Association Between Fibroblast Growth Factor Receptor 1 Gene Amplification and Human Papillomavirus Prevalence in Tonsillar Squamous Cell Carcinoma With Clinicopathologic AnalysisSoonchan Park, Miji Lee, Kyung-Ja Cho, et al.
Thyroid : Official Journal of the American Thyroid Association|July 1, 2017
Defining Radioiodine-Refractory Differentiated Thyroid Cancer: Efficacy and Safety of Lenvatinib by Radioiodine-Refractory Criteria in the SELECT TrialNaomi Kiyota, Bruce Robinson, Manisha Shah, et al.
Acta Oto-Laryngologica|November 7, 2017
Value of extranodal extension detected by computed tomography for predicting clinical response after chemoradiotherapy in head and neck squamous cell cancerHyun Moon, Young Jun Choi, Yoon Se Lee, et al.
International Journal of Molecular Sciences|November 25, 2023
The Neuroprotective Effects of <i>Dendropanax morbifera</i> Water Extract on Scopolamine-Induced Memory Impairment in MiceSung Bae Kim, Hyun Yeoul Ryu, Woo Nam, et al.
Plos One|February 17, 2016
Hepatoprotective Effect and Synergism of Bisdemethoycurcumin against MCD Diet-Induced Nonalcoholic Fatty Liver Disease in MiceSung-Bae Kim, Ok-Hwa Kang, Young-Seob Lee, et al.
Breast Cancer (Tokyo, Japan)|April 6, 2011
Biweekly gemcitabine-paclitaxel, gemcitabine-carboplatin, or gemcitabine-cisplatin as first-line treatment in metastatic breast cancer after anthracycline failure: a phase II randomized selection trialBinghe Xu, Zefei Jiang, Sung-Bae Kim, et al.
Breast Cancer Research and Treatment|May 4, 2007
Multicenter phase II trial of Genexol-PM, a Cremophor-free, polymeric micelle formulation of paclitaxel, in patients with metastatic breast cancerKeun Seok Lee, Hyun Cheol Chung, Seock Ah Im, et al.
European Journal of Cancer (Oxford, England : 1990)|August 20, 2013
A phase two randomised trial of neratinib monotherapy versus lapatinib plus capecitabine combination therapy in patients with HER2+ advanced breast cancerMiguel Martin, Jacques Bonneterre, Charles E Geyer, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|March 2, 2015
Tau and PTEN status as predictive markers for response to trastuzumab and paclitaxel in patients with HER2-positive breast cancerDong-Hoe Koo, Hee Jin Lee, Jin-Hee Ahn, et al.
Pageof 51